Medexus Pharmaceuticals Inc. – TSX:MDP.TO
Medexus Pharmaceuticals stock price today
Medexus Pharmaceuticals stock price monthly change
Medexus Pharmaceuticals stock price quarterly change
Medexus Pharmaceuticals stock price yearly change
Medexus Pharmaceuticals key metrics
Market Cap | 70.99M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | 113.05M |
EBITDA | 18.59M |
Income | -214K |
Revenue Q/Q | -9.32% |
Revenue Y/Y | 4.58% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 16.45% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedexus Pharmaceuticals stock price history
Medexus Pharmaceuticals stock forecast
Medexus Pharmaceuticals financial statements
| Jun 2023 | 31.55M | 651K | 2.06% |
|---|---|---|---|
| Sep 2023 | 30.32M | -1.09M | -3.6% |
| Dec 2023 | 25.21M | -534K | -2.12% |
| Mar 2024 | 25.96M | 762K | 2.94% |
| Mar 2024 | 25.96M | 762K | 2.94% |
|---|---|---|---|
| Sep 2025 | 38.52M | 3.57M | 9.28% |
| Dec 2025 | 39.19M | 3.62M | 9.25% |
| Mar 2026 | 39.80M | 3.48M | 8.77% |
Analysts Price target
Financials & Ratios estimates
| 2024-02-07 | -0.00773 | -0.02 |
|---|---|---|
| 2024-06-25 | 0.00857 | 0.03 |
| Jun 2023 | 166874000 | 144.14M | 86.38% |
|---|---|---|---|
| Sep 2023 | 166178000 | 144.43M | 86.92% |
| Dec 2023 | 160377000 | 130.81M | 81.57% |
| Mar 2024 | 155733000 | 125.41M | 80.53% |
| Jun 2023 | 4.21M | -597K | -968K |
|---|---|---|---|
| Sep 2023 | 7.35M | -592K | -2.96M |
| Dec 2023 | 5.54M | -1.75M | -15.15M |
| Mar 2024 | 1.60M | -538K | -3.96M |
Medexus Pharmaceuticals alternative data
| Aug 2023 | 98 |
|---|---|
| Sep 2023 | 98 |
| Oct 2023 | 98 |
| Nov 2023 | 98 |
| Dec 2023 | 98 |
| Jan 2024 | 98 |
| Feb 2024 | 98 |
| Mar 2024 | 98 |
| Apr 2024 | 98 |
| May 2024 | 98 |
| Jun 2024 | 98 |
| Jul 2024 | 82 |
Medexus Pharmaceuticals other data
-
What's the price of Medexus Pharmaceuticals stock today?
One share of Medexus Pharmaceuticals stock can currently be purchased for approximately $1.8.
-
When is Medexus Pharmaceuticals's next earnings date?
Unfortunately, Medexus Pharmaceuticals's (MDP.TO) next earnings date is currently unknown.
-
Does Medexus Pharmaceuticals pay dividends?
No, Medexus Pharmaceuticals does not pay dividends.
-
How much money does Medexus Pharmaceuticals make?
Medexus Pharmaceuticals has a market capitalization of 70.99M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47.4% to 113.05M US dollars. Medexus Pharmaceuticals made a loss 214K US dollars in net income (profit) last year or $0.03 on an earnings per share basis.
-
What is Medexus Pharmaceuticals's stock symbol?
Medexus Pharmaceuticals Inc. is traded on the TSX under the ticker symbol "MDP.TO".
-
What is Medexus Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Medexus Pharmaceuticals?
Shares of Medexus Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Medexus Pharmaceuticals have?
As Jul 2024, Medexus Pharmaceuticals employs 82 workers, which is 16% less then previous month and 16% less then previous quarter.
-
When Medexus Pharmaceuticals went public?
Medexus Pharmaceuticals Inc. is publicly traded company for more then 11 years since IPO on 9 Jan 2014.
-
What is Medexus Pharmaceuticals's official website?
The official website for Medexus Pharmaceuticals is medexus.com.
-
Where are Medexus Pharmaceuticals's headquarters?
Medexus Pharmaceuticals is headquartered at 35 Nixon Road, Bolton, ON.
-
How can i contact Medexus Pharmaceuticals?
Medexus Pharmaceuticals's mailing address is 35 Nixon Road, Bolton, ON and company can be reached via phone at 877 633 3987.
Medexus Pharmaceuticals company profile:
Medexus Pharmaceuticals Inc.
medexus.comTSX
82
Drug Manufacturers - Specialty & Generic
Healthcare
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a triamcinolone hexacetonide injectable suspension; and Gleolan, an optical imaging agent indicates for patients with glioma symptoms. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Bolton, Canada.
Bolton, ON L7E 1K1
:
ISIN: CA58410Q2036
:
